|
Arrhythmias, clinical electrophysiology, drugs
Citations 1-10 of 66 total displayed.
|
Most recent content
(1 Aug 2009):
|
- Research Letters
Score for the Targeting of Atrial Fibrillation (STAF): A New Approach to the Detection of Atrial Fibrillation in the Secondary Prevention of Ischemic Stroke
- Laurent Suissa, David Bertora, Sylvain Lachaud, and Marie Hélène Mahagne
Stroke 2009;40:2866-2868; published online before print as doi:10.1161/STROKEAHA.109.552679
[Abstract]
[Full text]
|
Past content
(since Apr 1999):
|
- Articles
Score for the Targeting of Atrial Fibrillation (STAF). A New Approach to the Detection of Atrial Fibrillation in the Secondary Prevention of Ischemic Stroke
- Laurent Suissa, David Bertora, Sylvain Lachaud, and Marie Hélène Mahagne
Stroke published May 21, 2009, doi:10.1161/STROKEAHA.109.552679
[Abstract]
- Original Contributions
Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
- David J. Gladstone, Esther Bui, Jiming Fang, Andreas Laupacis, M. Patrice Lindsay, Jack V. Tu, Frank L. Silver, and Moira K. Kapral
Stroke 2009;40:235-240; published online before print as doi:10.1161/STROKEAHA.108.516344
[Abstract]
[Full text]
- Original Contributions
Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
- Albert Yuh-Jer Shen, Janis F. Yao, Somjot S. Brar, Michael B. Jorgensen, Xunzhang Wang, and Wansu Chen
Stroke 2008;39:2736-2743; published online before print as doi:10.1161/STROKEAHA.107.508580
[Abstract]
[Full text]
- Original Contributions
Stroke Location and Association With Fatal Cardiac Outcomes: Northern Manhattan Study (NOMAS)
- Fred Rincon, Mandip Dhamoon, Yeseon Moon, Myunghee C. Paik, Bernadette Boden-Albala, Shunichi Homma, Marco R. Di Tullio, Ralph L. Sacco, and Mitchell S.V. Elkind
Stroke 2008;39:2425-2431; published online before print as doi:10.1161/STROKEAHA.107.506055
[Abstract]
[Full text]
- Articles
Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
- David J. Gladstone, Esther Bui, Jiming Fang, Andreas Laupacis, M. Patrice Lindsay, Jack V. Tu, Frank L. Silver, and Moira K. Kapral
Stroke published August 28, 2008, doi:10.1161/STROKEAHA.108.516344
[Abstract]
- Articles
Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
- Albert Yuh-Jer Shen, Janis F. Yao, Somjot S. Brar, Michael B. Jorgensen, Xunzhang Wang, and Wansu Chen
Stroke published July 17, 2008, doi:10.1161/STROKEAHA.107.508580
[Abstract]
- Articles
Stroke Location and Association With Fatal Cardiac Outcomes. Northern Manhattan Study (NOMAS)
- Fred Rincon, Mandip Dhamoon, Yeseon Moon, Myunghee C. Paik, Bernadette Boden-Albala, Shunichi Homma, Marco R. Di Tullio, Ralph L. Sacco, and Mitchell S.V. Elkind
Stroke published July 17, 2008, doi:10.1161/STROKEAHA.107.506055
[Abstract]
- Original Contributions
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 2008;39:1482-1486; published online before print as doi:10.1161/STROKEAHA.107.500199
[Abstract]
[Full text]
- Articles
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500199
[Abstract]
|
|
